0.4144  0.017 (4.15%)		05-13 14:42
Open: 0.39 High: 0.4144 Volume: 129,285		Pre. Close: 0.3979 Low: 0.39 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	0.54	1-year :	0.64
Resists	First :	0.46	Second :	0.54
Pivot price	0.39
Supports	First :	0.38	Second :	0.33
MAs	MA(5) :	0.4	MA(20) :	0.39
	MA(100) :	0.43	MA(250) :	0.82
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	36.7	D(3) :	37.6
RSI	RSI(14): 53.7
52-week	High :	2.59	Low :	0.23

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SCNX ] has closed below upper band by 29.3%. Bollinger Bands are 60.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.42 - 0.42	0.42 - 0.42
Low:	0.39 - 0.39	0.39 - 0.39
Close:	0.39 - 0.4	0.4 - 0.4

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Thu, 07 May 2026
Scienture (SCNX) Secures Patent for Innovative Losartan Suspensi - GuruFocus

Thu, 07 May 2026
Scienture Holdings Secures $11M Debt Financing Via Note Purchase Agreement >SCNX - Moomoo

Thu, 07 May 2026
$11M debt funds Scienture's hypertension drug and overdose spray - Stock Titan

Wed, 06 May 2026
Scienture Holdings Issues Updated Investor Presentation Disclosure - The Globe and Mail

Fri, 01 May 2026
Scienture Holdings Secures $11.42 Million in Secured Notes Financing From Streeterville Capital - TradingView

Wed, 15 Apr 2026
Scienture receives Nasdaq extension to regain compliance - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	0 (M)
Shares Float	41 (M)
Held by Insiders	3.279e+007 (%)
Held by Institutions	21.8 (%)
Shares Short	2,990 (K)
Shares Short P.Month	0 (K)

EPS	-1.579e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	1 %
Return on Assets (ttm)	869.8 %
Return on Equity (ttm)	-10.8 %
Qtrly Rev. Growth	431610 %
Gross Profit (p.s.)	0.01
Sales Per Share	0.01
EBITDA (p.s.)	-0.43
Qtrly Earnings Growth	-2.8 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	25.43
Price to Cash Flow	0

Dividend	0
Forward Dividend	1.72e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.